Literature DB >> 7488744

Induction of p21ras in Alzheimer pathology.

U Gärtner1, M Holzer, R Heumann, T Arendt.   

Abstract

Changes in the expression of the small G-protein p21ras, a critical regulator of cell proliferation and differentiation, were investigated by immunohistochemical methods in the temporal cortex of patients with Alzheimer's disease. In both normal brain and in Alzheimer's disease, the H-ras, K-ras and N-ras gene products were equally detected in almost all neurones and occasionally also in glial cells. In Alzheimer's disease an increased expression of p21ras was observed within neuritic plaques as well as in neurones and glial cells closely associated with plaques. Neurones containing tangle-bearing material also showed a high level of expression. It is suggested that activation of p21ras dependent signalling pathways are involved in the processes of neurodegeneration and/or aberrant repair in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488744     DOI: 10.1097/00001756-199507100-00020

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

Review 1.  The role of cell cycle-mediated events in Alzheimer's disease.

Authors:  A K Raina; M J Monteiro; A McShea; M A Smith
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

Review 2.  Protein prenylation and synaptic plasticity: implications for Alzheimer's disease.

Authors:  David A Hottman; Ling Li
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

3.  SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells.

Authors:  Dale Chaput; Lisa Hornbeck Kirouac; Harris Bell-Temin; Stanley M Stevens; Jaya Padmanabhan
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

4.  Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75.

Authors:  K Susen; A Blöchl
Journal:  J Mol Med (Berl)       Date:  2005-07-07       Impact factor: 4.599

Review 5.  The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.

Authors:  Sally Hunter; Thomas Arendt; Carol Brayne
Journal:  Mol Neurobiol       Date:  2013-04-03       Impact factor: 5.590

6.  Activation of amyloid precursor protein processing by growth factors is dependent on Ras GTPase activity.

Authors:  Loredana Amigoni; Michela Ceriani; Fiorella Belotti; Giuseppina Minopoli; Enzo Martegani
Journal:  Neurochem Res       Date:  2010-12-15       Impact factor: 3.996

Review 7.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

Review 8.  Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.

Authors:  Angela Jeong; Kiall Francis Suazo; W Gibson Wood; Mark D Distefano; Ling Li
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-06       Impact factor: 8.250

Review 9.  Biological Hallmarks of Cancer in Alzheimer's Disease.

Authors:  Kelly N H Nudelman; Brenna C McDonald; Debomoy K Lahiri; Andrew J Saykin
Journal:  Mol Neurobiol       Date:  2019-04-16       Impact factor: 5.590

Review 10.  Cellular senescence and Alzheimer disease: the egg and the chicken scenario.

Authors:  Sara Saez-Atienzar; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2020-06-29       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.